Drug Shortage Report for APO-VENLAFAXINE XR

Last updated on 2022-08-05 History
Report ID 165727
Drug Identification Number 02331705
Brand name APO-VENLAFAXINE XR
Common or Proper name VENLAFAXINE XR
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) VENLAFAXINE
Strength(s) 150MG
Dosage form(s) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL ORAL
Packaging size 100 BTL
ATC code N06AX
ATC description ANTIDEPRESSANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-07-26
Estimated end date 2022-10-03
Actual end date
Shortage status Actual shortage
Updated date 2022-08-05
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2022-07-29 English Compare
v2 2022-07-29 French Compare
v3 2022-08-05 English Compare
v4 2022-08-05 French Compare

Showing 1 to 4 of 4